Last week, TOPRA held its fourth annual gala to announce its Awards for Excellence in Regulatory Affairs.
Last week, TOPRA (The Organization for Professionals in Regulatory Affairs) held its fourth annual gala to announce its Awards for Excellence in Regulatory Affairs. Held in London, the 2013 awards again recognized inspiration, innovation, communication, support, a lifetime achievement award and more. CROs Parexel and PPD sponsored two of the awards.
Read the full release here.
Semaglutide Significantly Improves Steatohepatitis, Fibrosis in Phase III MASH Trial
May 2nd 2025Interim results from the Phase III ESSENCE trial published in The New England Journal of Medicine show once-weekly semaglutide improved liver histology, metabolic markers, and weight loss in patients with biopsy-confirmed metabolic dysfunction–associated steatohepatitis and stage 2 or 3 fibrosis.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.